Review
Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology

https://doi.org/10.1016/S0165-6147(00)89068-9Get rights and content

Abstract

Understanding the pharmacology of opioid receptors took a major step forward with the cloning of genes that encode four members of the opioid receptor family. Gavril Pasternak and Kelly Standifer show how strategies that use antisense oligodeoxynucleotides can provide a selective approach to correlate the properties of the cloned receptors with their in vivo pharmacological effects, and have confirmed the association of the δ-, μ- and κ1-opioid receptor clones with analgesia mediated through δ-, μ- and κ1-opioid receptors, respectively. Approaches that use antisense oligodeoxynucleotides provide an opportunity to characterize the pharmacology of short cDNA fragments without necessitating the cloning of the entire cDNA and can assess the role of the products of specific exons in a receptor, providing an approach for the study of alternative splicing as demonstrated with the μ- and κ3-opioid receptor clones.

References (57)

  • M. Minami

    FEBS Lett.

    (1993)
  • R.C. Thompson et al.

    Neuron

    (1993)
  • C.M. Eppler

    J. Biol. Chem.

    (1993)
  • T. Reisine et al.

    Trends Neurosci.

    (1993)
  • J.B. Wang

    FEBS Lett.

    (1994)
  • C.A. Kozak et al.

    Genomics

    (1994)
  • R.J. Knapp

    Life Sci.

    (1994)
  • L.A. Bare et al.

    FEBS Lett.

    (1994)
  • A. Zimprich et al.

    Regul. Peptides

    (1994)
  • Y. Chen

    FEBS Lett.

    (1994)
  • D. Keith et al.

    Regul. Peptides

    (1994)
  • Y-X. Pan et al.

    Regul. Peptides

    (1994)
  • G.R. Uhl et al.

    Trends Neurosci.

    (1994)
  • M.J. Wick

    Mol. Brain Res.

    (1994)
  • J.B. Wang

    FEBS Lett.

    (1994)
  • C. Mollereau

    FEBS Lett.

    (1994)
  • J.R. Bunzow

    FEBS Lett.

    (1994)
  • K. Fukuda

    FEBS Lett.

    (1994)
  • C. Wahlestedt

    Trends Pharmacol. Sci.

    (1994)
  • M. Zhang et al.

    Neurosci Lett.

    (1993)
  • K.M. Standifer et al.

    Neuron

    (1994)
  • G.C. Rossi et al.

    Life Sci.

    (1994)
  • G.C. Rossi et al.

    FEBS Lett.

    (1995)
  • C-C. Chien et al.

    Eur. J. Pharmacol.

    (1994)
  • L.F. Tseng et al.

    Eur. J. Pharmacol.

    (1994)
  • X.H. Chen

    Eur. J. Pharmacol.

    (1995)
  • J.U. Adams et al.

    Brain Res.

    (1994)
  • R.B. Raffa et al.

    Eur. J. Pharmacol.

    (1994)
  • Cited by (157)

    • Endogenous opioid modulation of food intake and body weight: Implications for opioid influences upon motivation and addiction

      2019, Peptides
      Citation Excerpt :

      The use of this knockdown strategy provides further converging evidence for a powerful role of opioid receptors, particularly the mu-opioid subtype in mediating homeostatically-driven feeding behavior, and also supports the contention of “positive addictive “properties of opioids. Opioid receptors mediate their effects through putative activation of G-proteins to which they are coupled and modulate the inhibition of cAMP [see reviews: 351,379,385]. In this series of studies, AS ODNs directed against different G-proteins were administered ventricularly, and their effects upon opioid- and homeostatically-induced feeding assessed.

    • Acute Pain

      2019, A Practice of Anesthesia for Infants and Children
    • Acute Pain

      2018, A Practice of Anesthesia for Infants and Children
    • Acute Pain

      2009, A Practice of Anesthesia for Infants and Children
    • Acute pain

      2008, A Practice of Anesthesia for Infants and Children: Expert Consult
    View all citing articles on Scopus
    View full text